Key facts
- Vestaron’s last known valuation is $551.0M (Apr 2025).
- It has raised $302.1M across 3 recorded rounds; the latest was Later Stage VC ($82.9M) in Jan 2025.
- Notable investors include Plug and Play Tech Center, National Institutes of Health, Eight Roads, Novo Holdings, Argonautic Ventures — 27 tracked in total.
- Vestaron has filed 3 Form Ds with the SEC since 2021, most recently Feb 2025 ($82.9M sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Vestaron
Funding rounds
3 roundsAbout Vestaron
Developer of peptide-based insecticides designed for sustainable crop protection. The company has developed a platform that uses naturally occurring peptides with novel modes of action, short re-entry and preharvest intervals, no residue restrictions, and low impact on pollinators and beneficials, enabling growers to protect yields, manage resistance, and reduce reliance on synthetic pesticides.
- Sector
- Materials and Resources
- HQ
- Durham, NC, United States
- Founded
- 2005
- Employees
- 51
- Website
- vestaron.com/
- Ownership
- Privately Held (backing)
Vestaron doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vestaron shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vestaron in its N-PORT filings yet. We sweep new filings monthly.